Clinical Course and Treatment Implications of Combination Immune Checkpoint Inhibitor-Mediated Hepatitis: A Multicentre Cohort.

J Can Assoc Gastroenterol · 2022 · PMC8806044 · PMID 35118226

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significanceP = 0.06so close (0.05 < p ≤ 0.1)

There was a trend toward a higher ALT:ULN ratio post-hepatitis resolution compared to baseline (1.4 versus 1.0) although this did not reach statistical significance ( P = 0.06).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.